SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-032445
Filing Date
2019-05-29
Accepted
2019-05-29 16:49:32
Documents
3
Period of Report
2019-05-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-10820_18k.htm 8-K 30781
2 EX-10.1 a19-10820_1ex10d1.htm EX-10.1 33025
3 GRAPHIC g108201kgi001.jpg GRAPHIC 6817
  Complete submission text file 0001104659-19-032445.txt   74762
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37852 | Film No.: 19862650
SIC: 2834 Pharmaceutical Preparations